Prospective identification of biologically active structures by topomer shape similarity searching

被引:84
作者
Cramer, RD
Poss, MA
Hermsmeier, MA
Caulfield, TJ
Kowala, MC
Valentine, MT
机构
[1] Tripos Inc, St Louis, MO 63366 USA
[2] Bristol Myers Squibb, Princeton, NJ 08546 USA
关键词
D O I
10.1021/jm990159q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The principle of bioisosterism-similarly shaped molecules are more likely to share biological properties than are other molecules-has long helped to guide drug discovery. An algorithmic implementation of this principle, based on shape comparisons of a single rule-generated "topomer" conformation per molecule, had been found to be the descriptor most consistently predictive of similar biological properties, in retrospective studies, and also to be well-suited for searching large (>10(12)) "virtual libraries" of potential reaction products. Therefore a prospective trial of this shape similarity searching method was carried out, with synthesis of 425 compounds and testing of them for inhibition of binding of angiotensin II (A-II). The 63 compounds that were identified by shape searching as most similar to any of four query structures included all of the seven compounds found to be highly active, with none of the other 362 structures being highly active (p < 0.001). Additional consistent relations (p < 0.05) were found, among all 425 compounds, between the degree of shape similarity to the nearest query structure and the frequency of various levels of observed activity. Known "SAR" (rules specifying structural features required for A-II antagonism) were also regenerated within the biological data for the 63 shape similar structures.
引用
收藏
页码:3919 / 3933
页数:15
相关论文
共 27 条
[1]   Molecular recognition of protein-ligand complexes: Applications to drug design [J].
Babine, RE ;
Bender, SL .
CHEMICAL REVIEWS, 1997, 97 (05) :1359-1472
[2]   NEW NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS .2. SYNTHESIS, BIOLOGICAL PROPERTIES, AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-ALKYL-4-(BIPHENYLYLMETHOXY)QUINOLINE DERIVATIVES [J].
BRADBURY, RH ;
ALLOTT, CP ;
DENNIS, M ;
FISHER, E ;
MAJOR, JS ;
MASEK, BB ;
OLDHAM, AA ;
PEARCE, RJ ;
RANKINE, N ;
REVILL, JM ;
ROBERTS, DA ;
RUSSELL, ST .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (22) :4027-4038
[3]   Use of structure Activity data to compare structure-based clustering methods and descriptors for use in compound selection [J].
Brown, RD ;
Martin, YC .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (03) :572-584
[4]  
Carini David John, 1989, Eur., V323, P841, Patent No. 323841
[5]  
CARR G, 1998, ECONOMIST 0221, P1
[6]   Bioisosterism as a molecular diversity descriptor: Steric fields of single ''topomeric'' conformers [J].
Cramer, RD ;
Clark, RD ;
Patterson, DE ;
Ferguson, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (16) :3060-3069
[7]   Virtual compound libraries: A new approach to decision making in molecular discovery research [J].
Cramer, RD ;
Patterson, DE ;
Clark, RD ;
Soltanshahi, F ;
Lawless, MS .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1998, 38 (06) :1010-1023
[8]   COMPARATIVE MOLECULAR-FIELD ANALYSIS (COMFA) .1. EFFECT OF SHAPE ON BINDING OF STEROIDS TO CARRIER PROTEINS [J].
CRAMER, RD ;
PATTERSON, DE ;
BUNCE, JD .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1988, 110 (18) :5959-5967
[9]   SMoG: de Novo design method based on simple, fast, and accurate free energy estimates .1. Methodology and supporting evidence [J].
DeWitte, RS ;
Shakhnovich, EI .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (47) :11733-11744
[10]   THE DISCOVERY OF DUP-753, A POTENT, ORALLY ACTIVE NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].
DUNCIA, JV ;
CARINI, DJ ;
CHIU, AT ;
JOHNSON, AL ;
PRICE, WA ;
WONG, PC ;
WEXLER, RR ;
TIMMERMANS, PBMWM .
MEDICINAL RESEARCH REVIEWS, 1992, 12 (02) :149-191